Immune aging score linked to shorter myeloma survival
Among patients diagnosed before 70, accelerated immune aging was linked to shorter survival after clinical adjustments, with a hazard ratio of 2.24.Among patients diagnosed before 70, accelerated immune aging was linked to shorter survival after clinical adjustments, with a hazard ratio of 2.24.